切换至 "中华医学电子期刊资源库"

中华妇幼临床医学杂志(电子版) ›› 2018, Vol. 14 ›› Issue (02) : 193 -198. doi: 10.3877/cma.j.issn.1673-5250.2018.02.011

所属专题: 文献

论著

蜕膜组织种植建立子宫内膜异位症模型的可行性分析
曹杨1, 刘颖蕾1, 刘宏斌1, 周峰1, 乔海风1, 开海丽1, 刘曼华1,()   
  1. 1. 226001 江苏,南通大学第二附属医院妇产科
  • 收稿日期:2017-08-30 修回日期:2018-02-05 出版日期:2018-04-01
  • 通信作者: 刘曼华

Feasibility analysis of establishing endometriosis model by decidua tissue implantation

Yang Cao1, Yinglei Liu1, Hongbin Liu1, Feng Zhou1, Haifeng Qiao1, Haili Kai1, Manhua Liu1,()   

  1. 1. Department of Gynecology and Obstetrics, Second Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China
  • Received:2017-08-30 Revised:2018-02-05 Published:2018-04-01
  • Corresponding author: Manhua Liu
  • About author:
    Corresponding author: Liu Manhua, Email:
引用本文:

曹杨, 刘颖蕾, 刘宏斌, 周峰, 乔海风, 开海丽, 刘曼华. 蜕膜组织种植建立子宫内膜异位症模型的可行性分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2018, 14(02): 193-198.

Yang Cao, Yinglei Liu, Hongbin Liu, Feng Zhou, Haifeng Qiao, Haili Kai, Manhua Liu. Feasibility analysis of establishing endometriosis model by decidua tissue implantation[J/OL]. Chinese Journal of Obstetrics & Gynecology and Pediatrics(Electronic Edition), 2018, 14(02): 193-198.

目的

探讨蜕膜组织中胎盘生长因子(PLGF),雌激素受体(ER)-α、-β表达特性,为建立子宫内膜异位症(EMS)模型提供理论依据。

方法

选择2016年8月至2017年2月,于南通大学第二附属医院就诊的101例女性为研究对象。术中在无菌条件下,分别获取其中38例剖宫产术孕妇子宫内的蜕膜组织38例,37例EMS患者(其中31例合并子宫肌瘤)的在位内膜31例及异位内膜37例,26例子宫肌瘤患者的正常内膜26例。采用免疫组织化学和实时荧光定量聚合酶链反应(qPCR)技术,检测这4种子宫内膜组织中PLGF,ER-α、-β的阳性表达率及其mRNA相对表达量。对蜕膜组织中的PLGF, EF-α、-β与其他3种子宫内膜组织中的这3种因子阳性表达率及其mRNA相对表达量分别进行统计学比较。本研究所有受试者均知情同意。

结果

①免疫组织化学方法检测结果显示:蜕膜组织中PLGF,ER-α、-β的阳性表达率(86.8%、84.2%、78.9%),均分别高于在位内膜(61.3%、58.1%、38.7%)、异位内膜(54.1%、35.1%、48.6%)及正常内膜(57.7%、53.8%、38.5%),并且差异均有统计学意义(χ2=6.003、5.849、15.298;χ2=9.723、18.812、7.469;χ2=6.996、7.041、10.796;均为P<0.05)。②qPCR检测结果显示:蜕膜组织PLGF,ER-α、-β mRNA相对表达量[(2.60±0.26)、(2.22±0.23)、(2.05±0.31)],均分别高于在位内膜[(1.23±0.09)、(1.08±0.13)、(0.95±0.14)],异位内膜[(1.96±0.22)、(0.38±0.06)、(1.50±0.35)]及正常内膜[(1.00±0.13)、(1.00±0.11)、(1.00±0.14)],并且差异均有统计学意义(t=21.243、15.263、15.382;t=9.939、20.093、8.112;t=20.532、15.628、17.282;均为P<0.001)。

结论

蜕膜组织具有较强的种植特性,有助于形成子宫内膜异位病灶,是建立EMS模型的良好载体。

Objective

To explore the expression characteristics of placental growth factor (PLGF), estrogen receptor (ER) -α and ER-β in decidua tissue, and to provide a theoretical basis for the establishment of endometriosis (EMS) model.

Methods

From August 2016 to February 2017, a total of 101 women in Second Affiliated Hospital of Nantong University were selected as research subjects. Under the aseptic condition, a total of 38 cases of decidua tissue were obtained from 38 pregnant women of caesarean section, 31 cases of eutopic endometrium and 37 cases of ectopic endometrium were obtained from 37 cases of EMS patients (including 31 cases with hysteromyoma), and 26 cases of normal endometrium were obtained from 26 cases of hysteromyoma patients. Immunohistochemistry and quantitative real-time polymerase chain reaction (qPCR) were used to detect the positive expression rate and mRNA relative expression levels of PLGF, ER-α and ER-β in these 4 types of endometrium tissues. The positive expression rate and mRNA relative expression levels of 3 factors in decidua tissue were statistically compared with those in other 3 endometrial tissues, respectively. All subjects in this study signed informed consents.

Results

①The results of immunohistochemical staining showed that the positive expression rates of PLGF, ER-α and ER-β in decidua tissue (86.8%, 84.2%, 78.9%) were all higher than those in eutopic endometrium (61.3%, 58.1%, 38.7%), ectopic endometrium (54.1%, 35.1%, 48.6%) and normal endometrium (57.7%, 53.8%, 38.5%), respectively, and all the differences were statistically significant (χ2=6.003, 5.849, 15.298; χ2=9.723, 18.812, 7.469; χ2=6.996, 7.041, 10.796, all P<0.05). ②The results of qPCR detection showed that the mRNA relative expression levels of PLGF, ER-α and ER-β in decidual tissue [(2.60±0.26), (2.22±0.23), (2.05±0.31)], were all higher than those in eutopic endometrium [(1.23±0.09), (1.08±0.13), (0.95±0.14)], ectopic endometrium [(1.96±0.22), (0.38±0.06), (1.50±0.35)] and normal endometrium [(1.00±0.13), (1.00±0.11), (1.00±0.14)], respectively, and all the differences were statistically significant (t=21.243, 15.263, 15.382; t=9.939, 20.093, 8.112; t=20.532, 15.628, 17.282; all P<0.001).

Conclusions

Decidua tissue has strong planting characteristics which are helpful to the formation of ectopic lesions, and it provides a good carrier for the establishment of EMS model.

图2 4种子宫内膜组织中胎盘生长因子表达的免疫组织化学图(图2A:蜕膜组织中PLGF表达呈强阳性;图2B:在位内膜中PLGF表达呈弱阳性;图2C:异位内膜中PLGF表达呈阳性;图2D:正常内膜中PLGF表达呈弱阳性)(SP法)
表1 4种子宫内膜组织中3种因子阳性表达率比较[例数(%)]
图4 4种子宫内膜组织中雌激素受体-β表达的免疫组织化学图(图4A:蜕膜组织中ER-β表达呈强阳性;图4B:在位内膜中ER-β表达呈弱阳性;图4C:异位内膜中ER-β表达呈阳性;图4D:正常内膜中ER-β表达呈弱阳性)(SP法)
表2 4种子宫内膜组织中3种因子mRNA相对表达量比较(±s)
[1]
LiYZ,WangLJ,LiX, et al. Vascular endothelial growth factor gene polymorphisms contribute to the risk of endometriosis: an updated systematic review and Meta-analysis of 14 case-control studies[J]. Genet Mol Res, 2013, 12(2): 1035-1044.
[2]
PellegriniC,GoriI,AchtariC, et al. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis[J]. Fertil Steril, 2012, 98(5): 1200-1208.
[3]
SoysalD,Kizildag˘S,Saatli B, et al. A novel angiogenesis inhibitor bevacizumab induces apoptosis in the rat endometriosis model[J]. Balkan J Med Genet, 2014, 17(2): 73-80.
[4]
CosínR,Gilabert-EstellésJ,RamónLA, et al. Influence of peritoneal fluid on the expression of angiogenic and proteolytic factors in cultures of endometrial cells from women with endometriosis[J]. Hum Reprod, 2010, 25(2): 398-405.
[5]
FischerC,JonckxB,MazzoneM, et al. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels[J]. Cell, 2007, 131(3): 463-475.
[6]
SantiA,FelserRS,MuellerMD, et al. Increased endometrial placenta growth factor (PLGF) gene expression in women with successful implantation[J]. Fertil Steril, 2011, 96(3): 663-668.
[7]
王竹辉,何福仙. 胎盘生长因子(PLGF)及其受体血管内皮生长因子受体-1(VEGFR-1)在子宫内膜异位症中的表达及意义[J]. 中国优生与遗传杂志, 2006, 14(10): 17-18.
[8]
CosínR,Gilabert-EstellésJ,RamónLA, et al. Vascular endothelial growth factor polymorphisms (-460C/T, +405G/C, and 936C/T) and endometriosis: their influence on vascular endothelial growth factor expression[J]. Fertil Steril, 2009, 92(4): 1214-1220.
[9]
BulunSE,ChengYH,PavoneME, et al. Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis[J]. Semin Reprod Med, 2010, 28(1): 36-43.
[10]
FujimotoJ,HiroseR,SakaguchiH, et al. Expression of oestrogen receptor-alpha and-beta in ovarian endometriomata[J]. Mol Hum Reprod, 1999, 5(8): 742-747.
[11]
SmucT,PuceljMR,SinkovecJ, et al. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis[J]. Gynecol Endocrinol, 2007, 23(2): 105-111.
[12]
BukulmezO,HardyDB,CarrBR, et al. Inflammatory status influences aromatase and steroid receptor expression in endometriosis[J]. Endocrinology, 2008, 149(3): 1190-1204.
[13]
TrukhachevaE,LinZ,ReierstadS, et al. Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis[J]. J Clin Endocrinol Metab, 2009, 94(2): 615-622.
[1] 张舒沁, 陈练. 产后宫腔内妊娠物残留的诊断和临床处理[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 493-497.
[2] 石皆春, 范子玉, 邢燕. 不同筛查方法预警宫颈原位腺癌的效能[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 575-581.
[3] 唐丹, 姚晓曦, 杨博文, 薛绍龙, 李梦瑶, 韦柳杏, 郄明蓉. 双肾上腺皮质激素样激酶1对子宫内膜样腺癌患者临床特征的影响[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(05): 582-590.
[4] 韩肖燕, 杨桦. 中孕期孕妇血清胎盘生长因子水平低与胎儿不良预后的关系[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(04): 398-402.
[5] 魏艺, 周羽西, 杨烨, 凌秀凤, 赵纯. 微小RNA对子宫内膜容受性影响的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 266-270.
[6] 林琳, 田思萌, 于永华, 徐飞飞, 黄明莉. 干细胞及其外泌体治疗宫腔黏连的研究现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 271-275.
[7] 李欣, 魏艺, 张娟, 张娟娟, 凌秀凤, 赵纯, 张媔秋. 高龄女性冻胚移植周期临床妊娠结局的影响因素分析[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(03): 276-283.
[8] 乔林. 子宫内膜异位症鉴别诊断病例分享[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 248-.
[9] 杨琳, 尹如铁. 外阴白色病变病因研究及治疗现状[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 157-165.
[10] 高伟聪, 李丽, 张中华, 朱向辉, 刘素巧. 宫颈癌患者糖调节受损对改良根治术后2年内复发的影响作用[J/OL]. 中华妇幼临床医学杂志(电子版), 2024, 20(02): 231-237.
[11] 胡启明, 鄢潇, 尤志学, 黄骁昊. 经瘢痕处单孔腹腔镜下切除多病灶腹壁子宫内膜异位症[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 314-317.
[12] 张蕾, 彭超, 周应芳. 直肠阴道隔子宫内膜异位症腹腔镜手术技巧[J/OL]. 中华腔镜外科杂志(电子版), 2024, 17(05): 257-261.
[13] 芦煜, 李振宇, 吴承东, 周仲伍. 肛周子宫内膜异位症一例报告[J/OL]. 中华结直肠疾病电子杂志, 2024, 13(05): 431-434.
[14] 陈娟, 邓静敏. 胸部子宫内膜异位综合征的研究进展[J/OL]. 中华临床医师杂志(电子版), 2024, 18(01): 96-100.
[15] 洪凡, 陈敦金, 傅洋, 梁新月, 吴毅, 王晓怡. 体外受精-胚胎移植妊娠合并前置胎盘临床研究[J/OL]. 中华产科急救电子杂志, 2024, 13(03): 176-182.
阅读次数
全文


摘要